We introduce StaphMark, a solution for the early detection of Staphylococcus aureus infections in orthopedic surgery. Our technology offers precision and non-invasive detection, enabling healthcare professionals to make accurate decisions and improve patient care.
StaphMark is our innovation in infection detection. Powered by the fully human monoclonal antibody 1D9, StaphMark serves as your guardian. It uncovers concealed Staphylococcus aureus infections with unparalleled precision. This advanced platform offers accurate, non-invasive, and swift diagnosis, enhancing patient care and surgical outcomes.
Our core innovation is the 1D9 fully human monoclonal antibody, a precision tool for detecting Staphylococcus aureus infections with unmatched accuracy.
StaphMark offers flexibility with both intravenous (IV) and intra-articular administration options, prioritizing patient comfort and healthcare professional convenience.
We proudly protect our cutting-edge technology with patents, ensuring an exclusive and groundbreaking solution.